Innovations In Clinical Neuroscience

JAN-FEB 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/796206

Contents of this Issue

Navigation

Page 49 of 63

Innovations in CLINICAL NEUROSCIENCE [ V O L U M E 1 4 , N U M B E R 1 – 2 , J A N U A R Y – F E B R U A R Y 2 0 1 7 ] 50 ataxia and male sterility (AMS) mouse. Brain Res. 2013;1494:109–117. 17. Cadet JL, Thiriet N, Jayanthi S. Involvement of free radicals in MDMA- induced neurotoxicity in mice. Ann Med Interne (Paris). 2001;152 Suppl 3:IS57–59. 18. de la Torre R, Farre M. Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci. 2004;25(10):505–508. 19. Fornai F, Gesi M, Lenzi P, et al. Effects of repeated low doses of MDMA on EEG activity and fluoro-jade B histochemistry. Ann N Y Acad Sci. 2004;1025:181–188. 20. Frenzilli G, Ferrucci M, Giorgi FS, et al. DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4- methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations. Behav Pharmacol. 2007;18(5-6):471–481. 21. Sharma HS, Ali SF. Acute administration of 3,4- methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. Ann N Y Acad Sci. 2008;1139:242–258. 22. Cho KO, Rhee GS, Kwack SJ, et al. Developmental exposure to 3,4- methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus. Neuroscience. 2008;154(3):1034–1041. 23. Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1997;337:986–994. 24. Valter DL, and Mattson MP. Fasting: Molecular Mechanisms and Clinical Applications. Cell Metab. 2014;19(2):181–192. 25. Ingram DK, Zhu M, Mamczarz J, et al. Calorie restriction mimetics: an emerging research field. Aging Cell. 2006;5:97–108. 26. Minor RK, Allard JS, Younts CM, et al. Dietary Interventions to Extend Life Span and Health Span Based on Calorie Restriction. J Gerontol A Biol Sci Med Sci. 2010;65(7):695–703. 27. Mattson MP. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 2012;16(6):706–722. 28. Mattson MP, Duan W, Guo Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem. 2003;84(3):417–431. 29. Prolla TA, Mattson MP. Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci. 2001;24(11 Suppl):S21–31. 30. Rothman SM, Griffioen KJ, Wan R, Mattson MP. Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci. 2012;1264:49–63. 31. Rothman SM, Mattson MP. Activity- dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan. Neuroscience. 2013;239:228–240. 32. Speakman JR, Mitchell SE. Caloric restriction. Mol Aspects Med. 2011;32(3):159–221. 33. Li L, Wang Z, Zuo Z. Chronic intermittent fasting improves cognitive functions and brain structures in mice. PLoS One. 2013;8(6):e66069. 34. Bondolfi L, Ermini F, Long JM, et al. Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL/6 mice. Neurobiol Aging. 2004;25(3):333–340. 35. Halagappa VK, Guo Z, Pearson M, et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple- transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2007;26(1):212–220. 36. Hsieh EA, Chai CM, Hellerstein MK. Effects of caloric restriction on cell proliferation in several tissues in mice: role of intermittent feeding. Am J Physiol Endocrinol Metab. 2005;288(5):E965–972. 37. Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem. 2002a;82(6):1367–1375. 38. Stranahan AM, Lee K, Martin B, et al. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus. 2009;19(10):951–961. 39. Wang J, Ho L, Qin W, et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2005;19(6):659–661. 40. Zhu H, Guo Q, Mattson MP. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 1999;842(1):224–229. 41. Duan W, Mattson MP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res.1999;57(2):195–206. 42. Carr KD. Food scarcity, neuroadaptations, and the pathogenic potential of dieting in an unnatural ecology: binge eating and drug abuse. Physiol Behav. 2011;104(1):162–167. 43. Khajeamiri AR, Kobarfard F, Ahmadkhaniha R, Mostashari G. Profiling of ecstasy tablets seized in Iran. Iran J Pharm Res. 2011;10(2):211–220. 44. Mueller M, Maldonado-Adrian C, Yuan J, et al. Studies of (+/-)-3,4- methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile. J Pharmacol Exp Ther. 2013;344(2):479–488. 45. Meyer JS, Piper BJ, Vancollie VE. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence. Ann N Y Acad Sci. 2008;1139:151–163. 46. Mager DE, Wan R, Brown M, et al. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J. 2006;20(6):631-7 47. Levay EA, Govic A, Penman J, et al. Effects of adult-onset calorie

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - JAN-FEB 2017